# Avery Dennison Corp: financial statements, quarterly

AVY · NYSE · CIK 8818 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avy.md) · [Financials](/companies/avy/financials.md) · [Filings](/companies/avy/filings.md) · [Insiders](/companies/avy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,098](/filings/0000008818-24-000017.md) | [2,111 d](/filings/0000008818-26-000015.md) | [2,151](/filings/0000008818-25-000012.md) | [2,235](/filings/0000008818-25-000040.md) | [2,183](/filings/0000008818-25-000049.md) | [2,186 d](/filings/0000008818-26-000015.md) | [2,148](/filings/0000008818-26-000109.md) | [2,221](/filings/0000008818-26-000131.md) | [2,216](/filings/0000008818-25-000049.md) | [2,271 d](/filings/0000008818-26-000015.md) | [2,299](/filings/0000008818-26-000109.md) | [2,463](/filings/0000008818-26-000131.md) |
| Cost of revenue | $m | [1,513](/filings/0000008818-24-000017.md) | [1,515 d](/filings/0000008818-26-000015.md) | [1,519](/filings/0000008818-25-000012.md) | [1,573](/filings/0000008818-25-000040.md) | [1,557](/filings/0000008818-25-000049.md) | [1,577 d](/filings/0000008818-26-000015.md) | [1,527](/filings/0000008818-26-000109.md) | [1,581](/filings/0000008818-26-000131.md) | [1,581](/filings/0000008818-25-000049.md) | [1,621 d](/filings/0000008818-26-000015.md) | [1,634](/filings/0000008818-26-000109.md) | [1,734](/filings/0000008818-26-000131.md) |
| Gross profit | $m | [586](/filings/0000008818-24-000017.md) | [596 d](/filings/0000008818-26-000015.md) | [632](/filings/0000008818-25-000012.md) | [663](/filings/0000008818-25-000040.md) | [627](/filings/0000008818-25-000049.md) | [609 d](/filings/0000008818-26-000015.md) | [622](/filings/0000008818-26-000109.md) | [639](/filings/0000008818-26-000131.md) | [635](/filings/0000008818-25-000049.md) | [651 d](/filings/0000008818-26-000015.md) | [665](/filings/0000008818-26-000109.md) | [729](/filings/0000008818-26-000131.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [325](/filings/0000008818-24-000017.md) | [335 d](/filings/0000008818-26-000015.md) | [365](/filings/0000008818-25-000012.md) | [374](/filings/0000008818-25-000040.md) | [347](/filings/0000008818-25-000049.md) | [329 d](/filings/0000008818-26-000015.md) | [347](/filings/0000008818-26-000109.md) | [352](/filings/0000008818-26-000131.md) | [354](/filings/0000008818-25-000049.md) | [369 d](/filings/0000008818-26-000015.md) | [375](/filings/0000008818-26-000109.md) | [395](/filings/0000008818-26-000131.md) |
| Interest expense | $m | [31.0](/filings/0000008818-23-000018.md) | [29.7 d](/filings/0000008818-24-000003.md) | [28.6](/filings/0000008818-24-000009.md) | [29.2](/filings/0000008818-25-000040.md) | [30.0](/filings/0000008818-25-000049.md) | [29.2 d](/filings/0000008818-26-000015.md) | [30.9](/filings/0000008818-26-000109.md) | [34.0](/filings/0000008818-26-000131.md) | [33.3](/filings/0000008818-25-000049.md) | [37.2 d](/filings/0000008818-26-000015.md) | [35.6](/filings/0000008818-26-000109.md) | [35.9](/filings/0000008818-26-000131.md) |
| Income tax | $m | [46.3](/filings/0000008818-24-000017.md) | [58.5 d](/filings/0000008818-26-000015.md) | [62.0](/filings/0000008818-25-000012.md) | [61.6](/filings/0000008818-25-000040.md) | [57.6](/filings/0000008818-25-000049.md) | [67.4 d](/filings/0000008818-26-000015.md) | [60.7](/filings/0000008818-26-000109.md) | [66.5](/filings/0000008818-26-000131.md) | [68.5](/filings/0000008818-25-000049.md) | [41.4 d](/filings/0000008818-26-000015.md) | [72.3](/filings/0000008818-26-000109.md) | [78.6](/filings/0000008818-26-000131.md) |
| Net income | $m | [138](/filings/0000008818-24-000017.md) | [143 d](/filings/0000008818-26-000015.md) | [172](/filings/0000008818-25-000012.md) | [177](/filings/0000008818-25-000040.md) | [182](/filings/0000008818-25-000049.md) | [174 d](/filings/0000008818-26-000015.md) | [166](/filings/0000008818-26-000109.md) | [189](/filings/0000008818-26-000131.md) | [166](/filings/0000008818-25-000049.md) | [166 d](/filings/0000008818-26-000015.md) | [168](/filings/0000008818-26-000109.md) | [204](/filings/0000008818-26-000131.md) |
| Diluted EPS | $ per share | [1.71](/filings/0000008818-24-000017.md) | not reported | [2.13](/filings/0000008818-25-000012.md) | [2.18](/filings/0000008818-25-000040.md) | [2.25](/filings/0000008818-25-000049.md) | not reported | [2.09](/filings/0000008818-26-000109.md) | [2.41](/filings/0000008818-26-000131.md) | [2.13](/filings/0000008818-25-000049.md) | not reported | [2.18](/filings/0000008818-26-000109.md) | [2.67](/filings/0000008818-26-000131.md) |
| Basic EPS | $ per share | [1.72](/filings/0000008818-24-000017.md) | not reported | [2.14](/filings/0000008818-25-000012.md) | [2.19](/filings/0000008818-25-000040.md) | [2.26](/filings/0000008818-25-000049.md) | not reported | [2.10](/filings/0000008818-26-000109.md) | [2.42](/filings/0000008818-26-000131.md) | [2.13](/filings/0000008818-25-000049.md) | not reported | [2.19](/filings/0000008818-26-000109.md) | [2.67](/filings/0000008818-26-000131.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [210](/filings/0000008818-23-000018.md) | [215](/filings/0000008818-25-000003.md) | [186](/filings/0000008818-24-000009.md) | [209](/filings/0000008818-24-000015.md) | [213](/filings/0000008818-24-000017.md) | [329](/filings/0000008818-26-000015.md) | [196](/filings/0000008818-25-000012.md) | [216](/filings/0000008818-25-000040.md) | [536](/filings/0000008818-25-000049.md) | [203](/filings/0000008818-26-000131.md) | [255](/filings/0000008818-26-000109.md) | [227](/filings/0000008818-26-000131.md) |
| Current assets | $m | [2,814](/filings/0000008818-23-000018.md) | [2,796](/filings/0000008818-25-000003.md) | [2,887](/filings/0000008818-24-000009.md) | [2,968](/filings/0000008818-24-000015.md) | [3,085](/filings/0000008818-24-000017.md) | [3,079](/filings/0000008818-26-000015.md) | [3,030](/filings/0000008818-25-000012.md) | [3,184](/filings/0000008818-25-000040.md) | [3,524](/filings/0000008818-25-000049.md) | [2,990](/filings/0000008818-26-000131.md) | [3,220](/filings/0000008818-26-000109.md) | [3,401](/filings/0000008818-26-000131.md) |
| Total assets | $m | [8,133](/filings/0000008818-23-000018.md) | [8,210](/filings/0000008818-25-000003.md) | [8,255](/filings/0000008818-24-000009.md) | [8,298](/filings/0000008818-24-000015.md) | [8,452](/filings/0000008818-24-000017.md) | [8,404](/filings/0000008818-26-000015.md) | [8,355](/filings/0000008818-25-000012.md) | [8,568](/filings/0000008818-25-000040.md) | [8,867](/filings/0000008818-25-000049.md) | [8,802](/filings/0000008818-26-000131.md) | [8,979](/filings/0000008818-26-000109.md) | [9,212](/filings/0000008818-26-000131.md) |
| Current liabilities | $m | [2,744](/filings/0000008818-23-000018.md) | [2,700](/filings/0000008818-25-000003.md) | [3,308](/filings/0000008818-24-000009.md) | [3,300](/filings/0000008818-24-000015.md) | [3,349](/filings/0000008818-24-000017.md) | [2,863](/filings/0000008818-26-000015.md) | [2,953](/filings/0000008818-25-000012.md) | [3,062](/filings/0000008818-25-000040.md) | [2,787](/filings/0000008818-25-000049.md) | [2,654](/filings/0000008818-26-000131.md) | [2,800](/filings/0000008818-26-000109.md) | [3,005](/filings/0000008818-26-000131.md) |
| Long-term debt | $m | not reported | [2,615](/filings/0000008818-25-000003.md) | not reported | not reported | not reported | [2,551](/filings/0000008818-26-000015.md) | not reported | not reported | not reported | [3,199](/filings/0000008818-26-000015.md) | not reported | not reported |
| Current portion of debt | $m | [716](/filings/0000008818-23-000018.md) | [622](/filings/0000008818-25-000003.md) | [1,171](/filings/0000008818-24-000009.md) | [1,172](/filings/0000008818-24-000015.md) | [1,117](/filings/0000008818-24-000017.md) | [592](/filings/0000008818-26-000015.md) | [878](/filings/0000008818-25-000012.md) | [922](/filings/0000008818-25-000040.md) | [579](/filings/0000008818-25-000049.md) | [523](/filings/0000008818-26-000131.md) | [605](/filings/0000008818-26-000109.md) | [501](/filings/0000008818-26-000131.md) |
| Shareholders' equity | $m | [2,064](/filings/0000008818-23-000018.md) | [2,128](/filings/0000008818-26-000015.md) | [2,204](/filings/0000008818-24-000009.md) | [2,287](/filings/0000008818-24-000015.md) | [2,394](/filings/0000008818-24-000017.md) | [2,312](/filings/0000008818-26-000015.md) | [2,171](/filings/0000008818-25-000012.md) | [2,202](/filings/0000008818-25-000040.md) | [2,211](/filings/0000008818-25-000049.md) | [2,242](/filings/0000008818-26-000131.md) | [2,301](/filings/0000008818-26-000109.md) | [2,323](/filings/0000008818-26-000131.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [323 d](/filings/0000008818-24-000017.md) | [312 d](/filings/0000008818-26-000015.md) | [120](/filings/0000008818-25-000012.md) | [198 d](/filings/0000008818-25-000040.md) | [270 d](/filings/0000008818-25-000049.md) | [351 d](/filings/0000008818-26-000015.md) | [(16.3)](/filings/0000008818-26-000109.md) | [209 d](/filings/0000008818-26-000131.md) | [312 d](/filings/0000008818-25-000049.md) | [377 d](/filings/0000008818-26-000015.md) | [137](/filings/0000008818-26-000109.md) | [408 d](/filings/0000008818-26-000131.md) |
| Capital expenditure | $m | [57.1 d](/filings/0000008818-24-000017.md) | [92.3 d](/filings/0000008818-26-000015.md) | [48.8](/filings/0000008818-25-000012.md) | [47.5 d](/filings/0000008818-25-000040.md) | [43.0 d](/filings/0000008818-25-000049.md) | [69.5 d](/filings/0000008818-26-000015.md) | [36.0](/filings/0000008818-26-000109.md) | [30.0 d](/filings/0000008818-26-000131.md) | [35.9 d](/filings/0000008818-25-000049.md) | [67.1 d](/filings/0000008818-26-000015.md) | [28.3](/filings/0000008818-26-000109.md) | [39.2 d](/filings/0000008818-26-000131.md) |
| Dividends paid | $m | [65.3 d](/filings/0000008818-24-000017.md) | [65.2 d](/filings/0000008818-26-000015.md) | [65.3](/filings/0000008818-25-000012.md) | [70.9 d](/filings/0000008818-25-000040.md) | [70.9 d](/filings/0000008818-25-000049.md) | [70.4 d](/filings/0000008818-26-000015.md) | [69.4](/filings/0000008818-26-000109.md) | [73.5 d](/filings/0000008818-26-000131.md) | [73.1 d](/filings/0000008818-25-000049.md) | [72.4 d](/filings/0000008818-26-000015.md) | [72.3](/filings/0000008818-26-000109.md) | [76.2 d](/filings/0000008818-26-000131.md) |
| Share repurchases | $m | [27.6 d](/filings/0000008818-24-000017.md) | [20.4 d](/filings/0000008818-26-000015.md) | [15.6](/filings/0000008818-25-000012.md) | [25.1 d](/filings/0000008818-25-000040.md) | [66.8 d](/filings/0000008818-25-000049.md) | [140 d](/filings/0000008818-26-000015.md) | [262](/filings/0000008818-26-000109.md) | [98.4 d](/filings/0000008818-26-000131.md) | [93.6 d](/filings/0000008818-25-000049.md) | [119 d](/filings/0000008818-26-000015.md) | [60.6](/filings/0000008818-26-000109.md) | [138 d](/filings/0000008818-26-000131.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.9](/filings/0000008818-23-000018.md) | [81.5](/filings/0000008818-24-000009.md) | [81.0](/filings/0000008818-24-000015.md) | [81.0](/filings/0000008818-24-000017.md) | [81.0](/filings/0000008818-25-000012.md) | [81.0](/filings/0000008818-25-000040.md) | [80.8](/filings/0000008818-25-000049.md) | [79.4](/filings/0000008818-26-000109.md) | [78.3](/filings/0000008818-26-000131.md) | [78.0](/filings/0000008818-25-000049.md) | [77.0](/filings/0000008818-26-000109.md) | [76.4](/filings/0000008818-26-000131.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,788,142 at 2026-08-01, from the cover of the [10-Q filed 2026-08-04](/filings/0000008818-26-000131.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.